
🔍 How to Use the Archive Search
Use the search bar below to explore the National Citizens Archive. This is a powerful tool designed to help you quickly locate specific information across reports, transcripts, videos, and exhibits.
​
Tips for Best Results:
-
Search by keywords or phrases
Enter a single word (e.g., vaccine, mandates, Charter) or a phrase (e.g., informed consent, adverse events). -
Use specific terms
The more precise your search, the more relevant your results will be. Try names, topics, or key terms from testimony. -
Try different variations
If you don’t find what you’re looking for, try synonyms or alternate wording. -
Results include multiple content types
Your search may return matches from reports, witness transcripts, video pages, and other archive materials. -
Results are ranked by relevance
The most relevant matches will appear first.
⏳ Please Be Patient
This archive contains a very large volume of content, including thousands of pages of testimony and documentation.
-
Initial results may take a few moments to load
-
If results appear incomplete, allow additional time for the search to fully populate
-
You can refine your search at any time to narrow results
đź’ˇ Helpful Tip
Once you open a document (such as a transcript or report), you can use your browser’s Find function (Ctrl+F or Cmd+F) to quickly locate specific words within that page.
Search results for "Autoimmune Conditions"
146 results found for "Autoimmune Conditions"
- NCI-R-01-Item-1-11 | National Citizens Ar
detailed reports of the tests made to establish the safety of the new drug for the purpose and under the conditions recommended; substantial evidence of the clinical effectiveness of the new drug for the purpose and under the conditions We will use terms and conditions to manage uncertainties or risk mitigation measures related to the vaccine
- NCI-R-01-Item-1-12 | National Citizens Ar
detailed reports of the tests made to establish the safety of the new drug for the purpose and under the conditions recommended; substantial evidence of the clinical effectiveness of the new drug for the purpose and under the conditions We will use terms and conditions to manage uncertainties or risk mitigation measures related to the vaccine
- NCI-R-01-Item-1-8 | National Citizens Ar
detailed reports of the tests made to establish the safety of the new drug for the purpose and under the conditions recommended; substantial evidence of the clinical effectiveness of the new drug for the purpose and under the conditions We will use terms and conditions to manage uncertainties or risk mitigation measures related to the vaccine
- NCI-R-01-Item-1-3 | National Citizens Ar
detailed reports of the tests made to establish the safety of the new drug for the purpose and under the conditions recommended; substantial evidence of the clinical effectiveness of the new drug for the purpose and under the conditions We will use terms and conditions to manage uncertainties or risk mitigation measures related to the vaccine
- NCI-R-01-Item-1-14 | National Citizens Ar
detailed reports of the tests made to establish the safety of the new drug for the purpose and under the conditions recommended; substantial evidence of the clinical effectiveness of the new drug for the purpose and under the conditions We will use terms and conditions to manage uncertainties or risk mitigation measures related to the vaccine
- NCI-R-01-Item-1-6 | National Citizens Ar
detailed reports of the tests made to establish the safety of the new drug for the purpose and under the conditions recommended; substantial evidence of the clinical effectiveness of the new drug for the purpose and under the conditions We will use terms and conditions to manage uncertainties or risk mitigation measures related to the vaccine
- NCI-R-01-Item-1-7 | National Citizens Ar
detailed reports of the tests made to establish the safety of the new drug for the purpose and under the conditions recommended; substantial evidence of the clinical effectiveness of the new drug for the purpose and under the conditions We will use terms and conditions to manage uncertainties or risk mitigation measures related to the vaccine
- NCI-R-01-Item-1-4 | National Citizens Ar
detailed reports of the tests made to establish the safety of the new drug for the purpose and under the conditions recommended; substantial evidence of the clinical effectiveness of the new drug for the purpose and under the conditions We will use terms and conditions to manage uncertainties or risk mitigation measures related to the vaccine
- NCI-R-02-Item-7-5-7 | National Citizens Ar
detailed reports of the tests made to establish the safety of the new drug for the purpose and under the conditions h) substantial evidence of the clinical effectiveness of the new drug for the purpose and under the conditions We will use terms and conditions to manage uncertainties or risk mitigation measures related to the vaccine
- NCI-R-04-Item-4-6-1 | National Citizens Ar
would normally develop affectionate relations. ” Bernet's Definition: “Parental alienation is a mental condition apply to cooperate on issues affecting the child; and (k) any civil or criminal proceeding, order, condition
- NCI-R-04-Item-3-1 | National Citizens Ar
Stephen Malthouse Vaccine schedule side effects & child informed consent 30 Tamara Main Daughter mental condition
- NCI-R-03-Item-5-4 | National Citizens Ar
protocols from the Front Line COVID-19 Critical Care Alliance (FLCCC), which have helped mitigate her condition Colleen was initially reluctant to take the COVID-19 vaccine due to her existing health condition, including By July 2022, he had developed a pulmonary embolism, a condition where a blood clot blocks an artery On December 23, 2021, as her husband’s condition deteriorated and he became non-responsive with low oxygen



